Cat. #162328
Glioblastoma WHO IV spheroid cell line, NCH663
Cat. #: 162328
Organism: Human
Tissue: Brain
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Christel Herold-Mende
Institute: Heidelberg University
Primary Citation: Rapp et al. 2017. Acta Neuropathol. 134(2):297-316. PMID: 28332095.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Glioblastoma WHO IV spheroid cell line, NCH663
- Cancer: Brain
- Organism: Human
- Tissue: Brain
- Growth properties: Mixed - adherent and suspension
- Description: Glioblastoma WHO IV spheroid cell line, NCH663
- Biosafety level: 2
Handling
- Growth medium: DMEM/F12 medium supplemented with 20 ng/mL EGF, 10 ng/mL FGF2, B27 (GIBCO), and ITSS (Roche)
- Temperature: 37°C
- Atmosphere: 5% CO2
References
- Rusu et al. 2019. Cell Stem Cell. 25(2):241-257. PMID: 31303549.
- Rapp et al. 2017. Acta Neuropathol. 134(2):297-316. PMID: 28332095.
